Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanja Kassuhn

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 19, 2016
CSEQ-SIMULATOR: A DATA SIMULATOR FOR CLIP-SEQ EXPERIMENTSWanja Kassuhn, Uwe Ohler, Philipp Drewe
Cancers|June 28, 2023
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer PatientsWanja Kassuhn, Pedro R Cutillas, Mirjana Kessler, et al.
Cancers|July 26, 2020
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-ImagingHagen Kulbe, Oliver Klein, Zhiyang Wu, et al.
Cancers|April 3, 2021
Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-ImagingWanja Kassuhn, Oliver Klein, Silvia Darb-Esfahani, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 19, 2016
CSEQ-SIMULATOR: A DATA SIMULATOR FOR CLIP-SEQ EXPERIMENTSWanja Kassuhn, Uwe Ohler, Philipp Drewe
Cancers|June 28, 2023
In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer PatientsWanja Kassuhn, Pedro R Cutillas, Mirjana Kessler, et al.
Cancers|July 26, 2020
Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-ImagingHagen Kulbe, Oliver Klein, Zhiyang Wu, et al.
Cancers|April 3, 2021
Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-ImagingWanja Kassuhn, Oliver Klein, Silvia Darb-Esfahani, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Pageof 1